BOSTON — General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as the industrial giant continues to shed pieces of itself. The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last ...

Tagged with: Danaher Corp. general electric

Read More »